Hodnota podniku společnosti Starpharma
Jaká je hodnota metriky Hodnota podniku společnosti Starpharma?
Hodnota metriky Hodnota podniku společnosti Starpharma Holdings Limited je $114.27M
Jaká je definice metriky Hodnota podniku?
Podniková hodnota (Enterprise value) je měřítkem celkové tržní hodnoty společnosti. Vypočítává se jako tržní kapitalizace s dluhem, menšinovým podílem a přednostními akciemi sníženými o celkovou hodnotu dostupných peněz a jejich ekvivalentů.
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Hodnota podniku společností v sektoru Health Care sektor na ASX ve srovnání se společností Starpharma
Čemu se věnuje společnost Starpharma?
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, the company develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase II clinical trial, and DEP irinotecan that is in phase II clinical trials for the treatment of cancer; oncology programs, such as DEP radiopharmaceuticals, DEP HER-2 ADC, and DEP gemcitabine; DEP non-oncology candidates; and DEP AZD0466, which is in Phase I/II clinical trials to treat haematological tumours. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
Firmy s metrikou hodnota podniku podobnou společnosti Starpharma
- Hodnota metriky Hodnota podniku společnosti Pure Gold Mining je $113.91M
- Hodnota metriky Hodnota podniku společnosti Suoxinda je $114.05M
- Hodnota metriky Hodnota podniku společnosti Amaroq Minerals Ltd je $114.10M
- Hodnota metriky Hodnota podniku společnosti Dixie je $114.16M
- Hodnota metriky Hodnota podniku společnosti smartphoto group NV je $114.18M
- Hodnota metriky Hodnota podniku společnosti Ramco Systems je $114.25M
- Hodnota metriky Hodnota podniku společnosti Starpharma je $114.27M
- Hodnota metriky Hodnota podniku společnosti Alpha Real Trust je $114.32M
- Hodnota metriky Hodnota podniku společnosti Sylogist je $114.35M
- Hodnota metriky Hodnota podniku společnosti ScS Plc je $114.38M
- Hodnota metriky Hodnota podniku společnosti Paragon ID SA je $114.38M
- Hodnota metriky Hodnota podniku společnosti Probe Metals je $114.42M
- Hodnota metriky Hodnota podniku společnosti Zoetic International Plc je $114.43M